全身振动与运动治疗相结合在ACL重建后对跳跃着陆稳定的影响:一项随机对照试验
Roya Khanmohammadi1, Zahra Rostampour2
1Assistant Professor, PhD, PT, Iranian Center of Excellence in Physiotherapy, Rehabilitation Research Center, Department of Physiotherapy, School of Rehabilitation Sciences, Iran University of Medical Sciences, Tehran, Iran.
PloS one
|February 10, 2026
概括
全身振动 (WBV) 添加到炼显著改善跳跃着陆稳定性在运动员后前十字带重建 (ACLR). 然而,与单独的运动相比,WBV并没有为动态平衡或跳跃性能提供额外的好处.
科学领域:
- 整形外科 整形外科 整形外科
- 运动医学 运动医学
- 康复科学 康复科学 康复科学
背景情况:
- 前十字带重建 (ACLR) 往往导致动态姿势稳定性受损.
- 恢复动态平衡和身体功能对于ACLR后回归体育运动的运动员至关重要.
- 全身振动 (WBV) 在增强康复结果中的作用需要进一步研究.
研究的目的:
- 调查将WBV纳入炼程序对ACLR运动员跳跃着陆期间动态姿势稳定性的影响.
- 通过Y平衡测试 (YBT) 和通过四肢对称指数 (LSI) 评估WBV对动态平衡的影响.
主要方法:
- 一个随机,单盲,受控试验,涉及30名ACLR参与者.
- 参与者被分配到WBV加炼组或仅炼组.
- 在干预前和后进行了稳定性,平衡性和跳跃性能的评估.
主要成果:
- 与对照组不同的是,WBV组在跳跃着陆期间的稳定时间 (TTS) 显著改善.
- 两组在Y平衡测试 (YBT) 评分和从跳测试中获得的四肢对称指数 (LSI) 中表现出相似的改善.
- WBV证明了有选择性的好处,主要是增强TTS,没有为YBT或LSI提供额外的优势.
结论:
- 将WBV添加到标准练习中可以在跳跃着陆期间选择性地改善ACLR运动员的动态姿势稳定性 (TTS).
- 在这个人群中,WBV似乎不会为动态平衡 (YBT) 或跳跃表现 (LSI) 提供比单独运动更多的补充益处.
- 进一步的研究可能会探索全面ACLR康复的最佳WBV参数.
相关概念视频
The Colonization of Land
37.8K
Changes in the environment of the early Earth drove the evolution of organisms. As prokaryotic organisms in the oceans began to photosynthesize, they produced oxygen. Eventually, oxygen saturated the oceans and entered the air, resulting in an increase in atmospheric oxygen concentration, known as the oxygen revolution approximately 2.3 billion years ago. Therefore, organisms that could use oxygen for cellular respiration had an advantage. More than 1.5 years ago, eukaryotic cells and...
37.8K
Buoyancy and Stability for Submerged and Floating Bodies
2.6K
In fluid mechanics, buoyancy and stability are key concepts for understanding the behavior of submerged and floating bodies. When a stationary body is fully or partially submerged in a fluid, the fluid exerts a force on the body known as the buoyant force. This force acts vertically upward through a point called the center of buoyancy, which is the center of the displaced fluid volume. According to Archimedes' principle, the magnitude of the buoyant force is equal to the weight of the fluid...
2.6K
Combination Therapies and Personalized Medicine
6.2K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
6.2K
Hydraulic Jump: Problem Solving
562
To analyze a hydraulic jump in a rectangular channel with a flow speed of 6 meters per second, follow these steps:Calculate Effective Upstream Velocity:When the downstream gate closes, a hydraulic jump forms, traveling upstream at 2 meters per second. This wave speed combines with the initial channel flow velocity, creating an effective upstream velocity.Identify Flow Velocities Before and After the Hydraulic Jump:Upstream of the hydraulic jump, the effective flow velocity includes both the...
562
Hydraulic Jump
701
A hydraulic jump is a sudden rise in fluid depth in open channels, occurring when high-velocity (supercritical) flow transitions to low-velocity (subcritical) flow. This phenomenon requires an upstream Froude number greater than 1, as flows with Fr1<1 remain subcritical, making a hydraulic jump impossible due to the need for negative head loss, which violates thermodynamic principles.The characteristics of a hydraulic jump depend on the upstream Froude number and are classified as...
701
Drug Control Governance: Regulatory Bodies and Their Impact
570
Drug control governance involves the oversight and regulation of pharmaceuticals to ensure their safety and efficacy while preventing illegal drug use and trafficking. Regulatory bodies, including the US Food and Drug Administration (FDA) and the European Union's European Medicines Agency (EMA), play a central role in this process. These agencies evaluate the safety and efficacy of drugs before they can be marketed. They fund clinical trials and assess the benefits and risks associated with...
570


